Neng Jiang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Drug Administration

Cognitive Decline

Top Venues

Drug design, development and therapy

The Journal of endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Shu-Tong Huang, Jin-Chong Luo, Guo-Hui Zhong, Li-Ping Teng, Cai-Yan Yang, Chun-Li Tang, Lin Jing, Zhong-Bo Zhou, Jing Liu, Neng Jiang
In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease. Drug design, development and therapy 18 (2024)
Shu-Tong Huang, Jin-Chong Luo, Guo-Hui Zhong, Li-Ping Teng, Cai-Yan Yang, Chun-Li Tang, Lin Jing, Zhong-Bo Zhou, Jing Liu, Neng Jiang
In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease. Drug design, development and therapy 18 (2024)
Xianxian Huang, Jing Liu, Guangquan Peng, Mingyue Lu, Zhongbo Zhou, Neng Jiang, Zhiming Yan
Gut hormone multi-agonists for the treatment of type 2 diabetes and obesity: advances and challenges. The Journal of endocrinology 262 (3) (2024)
Shu-Tong Huang, Jin-Chong Luo, Guo-Hui Zhong, Li-Ping Teng, Cai-Yan Yang, Chun-Li Tang, Lin Jing, Zhong-Bo Zhou, Jing Liu, Neng Jiang
In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease. Drug design, development and therapy 18 (2024)
Xianxian Huang, Jing Liu, Guangquan Peng, Mingyue Lu, Zhongbo Zhou, Neng Jiang, Zhiming Yan
Gut hormone multi-agonists for the treatment of type 2 diabetes and obesity: advances and challenges. The Journal of endocrinology 262 (3) (2024)